医美巨头“炮轰”一众券商 称玻尿酸“遭谎言与践踏”

Core Viewpoint - The article discusses the criticism from Huaxi Biological towards several brokerage firms for their misleading research reports that promote the idea of hyaluronic acid being outdated compared to recombinant collagen protein, which Huaxi believes misleads the market and damages the reputation of the hyaluronic acid industry [1][4][5]. Group 1: Criticism of Brokerage Reports - Huaxi Biological accuses brokerage firms such as Western Securities, Anxin Securities, and Xinda Securities of publishing misleading conclusions that favor recombinant collagen over hyaluronic acid [1][4][5]. - Specific examples of misleading statements include claims that recombinant collagen has more biological features and safety advantages compared to hyaluronic acid [4][5]. - Huaxi Biological emphasizes that both hyaluronic acid and collagen are essential components of the extracellular matrix and should not be compared in a misleading manner [5][12]. Group 2: Market Dynamics - The article highlights the contrasting performance of Huaxi Biological and Juzhi Biological, with Huaxi experiencing a decline in revenue and market value while Juzhi shows significant growth [10][11]. - Huaxi Biological's revenue and net profit for 2024 are projected to be 5.371 billion and 174 million respectively, reflecting a year-on-year decline of 11.61% and 70.59% [10]. - In contrast, Juzhi Biological is expected to achieve a revenue of 5.539 billion and a net profit of 2.062 billion in 2024, marking a year-on-year growth of 57.07% and 42.06% [11]. Group 3: Industry Response - Following Huaxi Biological's statements, two industry associations issued a joint initiative advocating for scientific integrity and ethical marketing practices in the beauty and medical aesthetics sectors [8]. - Huaxi Biological claims to have received apologies from some brokerage firms and has reported the misleading content to regulatory authorities [6][12]. - The company asserts that the rise of the "outdated hyaluronic acid" narrative is a result of speculative capital creating a false narrative to shift focus towards new investment themes [13][14].